Amanote Research

Amanote Research

    RegisterSign In

Targeted Combo Effective for Refractory Ewing Sarcoma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2012-035
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

April 2, 2012

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)


Related search

Targeted Therapy in Ewing Sarcoma

ISRN Oncology
2012English

Tema 2-2014: Sarcoma De Ewing

Revista Clínica Escuela de Medicina UCR-HSJD
2014English

DNA Methylation Profiling Opens a New Phase in the Search of Targeted Therapy Against Ewing Sarcoma

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2017English

TTB2 Induces Apoptosis in Ewing Sarcoma Cells

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

BCL2/MDM2 Inhibitor Combo Effective in AML

Cancer Discovery
Oncology
2019English

A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Targeting Glutathione S-Transferase M4 in Ewing Sarcoma

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2014English

Drug Combo May Be Effective in Ovarian Cancer

Cancer Discovery
Oncology
2014English

Second Malignancies in Patients Treated for Ewing Sarcoma: A Systematic Review

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy